ProDERM study results of Octagam® 10% treatment in patients with dermatomyositis published in the New England Journal of Medicine

Octapharma announced today the results from the ProDERM study on the efficacy and safety of Octagam® 10% [Immune Globulin Intravenous (Human)], in adult dermatomyositis (DM) patients have been published in the New England Journal of Medicine (Aggarwal R et al. “Trial of Intravenous Immune Globulin in Dermatomyositis”) Click here for more details

Continue Reading

Today is National Myositis Awareness Day and we honor our HEROES!

On September 25, 2006, the US House of Representatives approved the goals and ideals of a “National Myositis Awareness Day” to be observed on September 21. The proclamation endorsing National Myositis Awareness Day capped a years-long effort by The Myositis Association. Today, many states and localities across the country recognize and celebrate the day with…

Continue Reading

Medicare Coverage of Seat Elevation and Standing Systems – Public Comments Accepted Through September 14, 2022

PLEASE ACT! The request that Medicare begin funding power seat elevation and standing systems has been in the works for some time.  The Medicare program currently denies coverage for seat elevation and standing systems in power wheelchairs. This means that Medicare beneficiaries with mobility impairments are forced to go without medically necessary wheelchair technology if…

Continue Reading

Peter Frampton is supporting The Myositis Association!

One lucky fan is going to win the Ultimate Peter Frampton Fan Experience to include a 30 minute virtual meeting with Peter Frampton himself! Grammy-winning guitarist Peter Frampton is one of the most celebrated artists and guitarists in rock history. At 16, he was lead singer and guitarist for British band the Herd. At 18,…

Continue Reading